CERTA recently put into practice the first pilot and demonstration plant for the packaging of liquid foods treated with ultra high pressure homogenization (UHPH). This technology, the result of the university research, makes it possible to offer a more stable preservation of juices, dairy products wines and broth in cartons at room temperature and without using additives.
The UAB Research Park organises two information sessions to present the 10th edition of the Ideas Generation Programme, focused on smart food challenges. Sessions will take place on 13 Sept at 10 a.m., and 17 Sept at 12 noon, at the Faculty of Sciences and Biosciences.
Researchers of the ICMAB-CSIC, together with the company Nanomol Technologies S.L. have begun a consultation process with the Spanish Association of Medicines and Health Products to try and enter a new treatment in a clinical studies stage, to fight against venous ulcers in lower extremities. The study is carried out .
Jordi Sort, ICREA researcher at the Department of Physics, was awarded one of the ERC's Proof of Concept grants. ICMAB researcher Teresa Puig was also awarded the same grant.
The programme's 10th edition is addressed to PhD students and researchers interested in solving smart food challenges: reducing food waste, eliminating plastics or decreasing the use of antibiotics.
The UAB awarded the grants included in its first "Proof of Concept" call in an event celebrated on 2 July at the Digital Lab of the UAB Open Labs. Four research projects received a total of 200,000 euros, co-funded with the European Regional Development Fund (ERDF).
The UAB received a total of four grants from the Innovative Training Networks (ITN), with the aim of training a new generation of creative and innovative researchers through an international network of public and private research centres.
The UAB, the UAB Research Park, the Eurecat Technological Centre, and the Association B30 Area recently signed an agreement to incorporate these two entities as new members of the Hub b30 platform.
Researchers from the IBB-UAB will develop a research project with the company Pharmacelera to find new molecules capable of blocking the alpha-synucleic protein, the accumulation of which is the main factor causing Parkinson's disease.